Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-20
2007-11-20
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S462000, C514S468000, C514S510000
Reexamination Certificate
active
10915821
ABSTRACT:
The present invention is concerned with treatment of sleep disorders by administering a cholinesterase inhibitor, and in particular, by administering galantamine or a pharmaceutically acceptable salt thereof. Also in particular, cholinesterase inhibitors that are active at nicotinic receptors and that are selective for acetylcholinesterase over butylcholinesterase are used in treating sleep disorders.
REFERENCES:
patent: 5585375 (1996-12-01), Davis
patent: 0 515 302 (1992-11-01), None
patent: WO 97/22339 (1997-06-01), None
patent: WO00/25821 (2000-05-01), None
patent: WO 01/30318 (2001-05-01), None
patent: WO 2004/034963 (2004-04-01), None
2006 Chemical Abstracts Service Catalog, published by Chemical Abstracts Service, p. 52.
Merck Manual of Diagnosis and Therapy, Seventeenth Edition, Beers et al., ed., (1999), Chapter 179, pp. 1409-1417.
Timofeeva et al. “EEG Spectra, behavioral states, and motor activity in rats exposed to acetylcholinesterase inhibitor chlorpyrifos” Pharmacology, Biochemistry, and Behavior (2002) vol. 72, pp. 669-679.
Banji et al. “Emergent Complications Following Donepezil Switchover to Galantamine in THree Cases of Dementia With Lewy Bodies” The Journal of Neuropsychiatry and Clinical Neurosciences (2005) vol. 17, No. 4, pp. 552-555.
PCT International Search Report, dated Feb. 11, 2005, for PCT Int'l. Appln. No. PCT/US2004/026243.
Appollina Mary
Janssen Pharmaceutica N.V.
Jiang Shaojia Anna
Olson Eric S
LandOfFree
Treatment of sleep disorders with cholinesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of sleep disorders with cholinesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sleep disorders with cholinesterase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3849959